Search

everythinglearnresearchcommunity

for

Search:↓

Combined BRAF and MEK treatment increases rash risk but reduces other skin issues compared to BRAF alone.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

Inhibiting certain proteins harms hair follicle immunity and increases IL-33, affecting hair health.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

SOX4 is crucial for the development of melanoma.

Cancer treatments often cause skin, nail, and hair problems.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Phosphatidic acid may help hair grow by affecting cell growth pathways.

Procyanidin compounds from apples and barley promote hair growth and prevent hair cell death.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Biological therapy boosts the immune system to effectively fight melanoma.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Patients with melanoma who saw dermatologists and were from higher-income areas were more likely to have follow-up visits, which was linked to lower mortality.

Blocking certain fat production can reverse skin inflammation and hair loss.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Human placenta helps hair grow back after chemotherapy by blocking cell death and increasing hair follicle growth.

WYE-130600 may cause skin thickening and irritation.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.